Single-stage LC + LCBDE
OtherCholedochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration
NCT Number: NCT06974045
Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC).
Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training.
The investigators analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.
Looking for future studies?
Notify MeAll sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Choledochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration
Time frame: 90 days
Number of participants, size of choledochoscope used, rate of holmium laser lithotripsy use and stone clearance rates
Time frame: 90 days
Number of participants, number of complications (e.g. bile leak and pancreatitis), duration of hospital length of stay
Imperial College London
Other
Evaluation of a Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service Pre-, Intra- and Post-COVID-19 Pandemic: a Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03470584
Arthritis, Behavior
Chiayi City, Taiwan
View Trial DetailsNCT06969144
Biliary Tract Diseases, Calculi
Kathmandu, Nepal
View Trial DetailsNCT06953713
Biliary Tract Diseases, Calculi
Istanbul, Umraniye, Turkey (Türkiye)
View Trial DetailsNCT06223061
Bile Duct Injury, Biliary Tract Diseases
Edinburgh, United Kingdom
View Trial Details